The Drug Controller General of India (DCGI) has approved the clinical trial proposal for convalescent plasma therapy submitted by the Indian Council of Medical Research (ICMR) on April 17. The DCGI has given the nod for the clinical trial using plasma from recovered Covid-19 individuals to be transfused into sick patients to understand whether this can be a potential treatment for the pandemic. The trial will enrol 226 Covid-19 patients in the intervention group, who will receive plasma transfusion, and 226 Covid-19 patients in the control group, who will not receive the treatment.
#COVID19 , #CoronavirusLockdown , #CoronavirusOutbreak
